PL360592A1 - Sól tiazolidynodionu do leczenia cukrzycy - Google Patents

Sól tiazolidynodionu do leczenia cukrzycy

Info

Publication number
PL360592A1
PL360592A1 PL36059201A PL36059201A PL360592A1 PL 360592 A1 PL360592 A1 PL 360592A1 PL 36059201 A PL36059201 A PL 36059201A PL 36059201 A PL36059201 A PL 36059201A PL 360592 A1 PL360592 A1 PL 360592A1
Authority
PL
Poland
Prior art keywords
treatment
diabetes mellitus
thiazolidinedione
salt
thiazolidinedione salt
Prior art date
Application number
PL36059201A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of PL360592A1 publication Critical patent/PL360592A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PL36059201A 2000-06-08 2001-06-08 Sól tiazolidynodionu do leczenia cukrzycy PL360592A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
PL360592A1 true PL360592A1 (pl) 2004-09-20

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36059201A PL360592A1 (pl) 2000-06-08 2001-06-08 Sól tiazolidynodionu do leczenia cukrzycy

Country Status (23)

Country Link
EP (1) EP1296980A1 (pl)
JP (1) JP2003535862A (pl)
KR (1) KR20030007918A (pl)
CN (1) CN1443186A (pl)
AP (1) AP2002002673A0 (pl)
AU (1) AU2001264078A1 (pl)
BG (1) BG107357A (pl)
BR (1) BR0111536A (pl)
CA (1) CA2411065A1 (pl)
CZ (1) CZ20023966A3 (pl)
DZ (1) DZ3382A1 (pl)
EA (1) EA200300005A1 (pl)
GB (1) GB0014006D0 (pl)
HU (1) HUP0301137A3 (pl)
IL (1) IL153279A0 (pl)
MA (1) MA25753A1 (pl)
MX (1) MXPA02012100A (pl)
NO (1) NO20025883L (pl)
OA (1) OA12284A (pl)
PL (1) PL360592A1 (pl)
SK (1) SK17142002A3 (pl)
WO (1) WO2001094344A1 (pl)
ZA (1) ZA200209954B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US20080176905A1 (en) * 2007-01-22 2008-07-24 Santiago Ini Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EP1296980A1 (en) 2003-04-02
WO2001094344A1 (en) 2001-12-13
CN1443186A (zh) 2003-09-17
CA2411065A1 (en) 2001-12-13
CZ20023966A3 (cs) 2003-04-16
NO20025883D0 (no) 2002-12-06
BG107357A (bg) 2003-08-29
MA25753A1 (fr) 2003-04-01
AP2002002673A0 (en) 2002-12-31
NO20025883L (no) 2003-02-03
MXPA02012100A (es) 2003-04-25
BR0111536A (pt) 2003-07-01
AU2001264078A1 (en) 2001-12-17
DZ3382A1 (fr) 2001-12-13
EA200300005A1 (ru) 2003-04-24
JP2003535862A (ja) 2003-12-02
SK17142002A3 (sk) 2003-10-07
OA12284A (en) 2003-11-10
HUP0301137A2 (hu) 2003-08-28
ZA200209954B (en) 2003-10-10
KR20030007918A (ko) 2003-01-23
HUP0301137A3 (en) 2005-04-28
GB0014006D0 (en) 2000-08-02
IL153279A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
PL370818A1 (pl) Forma dawkowania przeznaczona do leczenia cukrzycy
MXPA03006936A (es) Tratamiento de diabetes mellitus.
EG24124A (en) Pharmaceutical compositions for the treatment of type-II diabetes mellitus
IL147822A0 (en) Benzoic acid derivatives for the treatment of diabetes mellitus
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
AU2001282873A1 (en) Quinuclidine-substituted aryl compounds for treatment of disease
IL218909A0 (en) Treatment of diabetes
AU2001284645A1 (en) Quinuclidine-substituted aryl compounds for treatment of disease
IL138784A0 (en) Treatment for diabetes
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
PL377164A1 (pl) Pochodne anilinopirazolu przydatne do leczenia cukrzycy
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
IL162853A0 (en) The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
IL153279A0 (en) Thiazolidinedione salt for treatment of diabetes mellitus
AU2003260813A8 (en) Improved process for preparation of thiazolidinedione derivatives
AP2003002738A0 (en) Tartrate salt of thiazolidinedione derivative
GB2355189B (en) Herbal preparation for the treatment of diabetes mellitus
HK1056551A (en) Thiazolidinedione salt for treatment of diabetes mellitus
AU6478900A (en) Novel use of angelan from angelica gigas for treating diabetes mellitus
HRP20030068A2 (en) Tartrate salt of thiazolidinedione derivative
GB0212790D0 (en) Medicament for the treatment of diabetes
GB0106468D0 (en) Treatment of diabetes mellitus
EP1377289A4 (en) HETEROCYCLIC COMPOUNDS WITH THERAPEUTIC USE
SI1383523T1 (sl) Sredstvo za zdravljenje diabetes mellitusa

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)